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Summary
SCF (Skp1-Cullin-F-box) ubiquitin ligases comprise several dozen modular enzymes that have 
diverse roles in biological regulation. SCF enzymes share a common catalytic core containing 
Cul1•Rbx1, which is directed towards different substrates by a variable substrate receptor (SR) 
module comprising one of 69 F-box proteins bound to Skp1. Despite the broad cellular impact of 
SCF enzymes, important questions remain about the architecture and regulation of the SCF 
repertoire, including whether SRs compete for Cul1, and if so, how this competition is managed. 
Here, we devise methods that preserve the in vivo assemblages of SCF complexes, and apply 
quantitative mass spectrometry to perform a census of these complexes (the ‘SCFome’) in various 
states. We show that Nedd8 conjugation and the SR exchange factor Cand1 have a profound effect 
on shaping the SCFome. Together, these factors enable rapid remodeling of SCF complexes to 
promote biased assembly of SR modules bound to substrate.
ETOC
*Correspondence: Deshaies@caltech.edu.
4Lead Contact
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Author Contributions
Conceptualization, J.M.R. and R.J.D.; Experimentation, J.M.R., X.L., and K.M.R., Resources, J.M.R., X.L., K.M.R., A.M., and S.H.; 
Funding Acquisition and Supervision, J.M.R., X.L., S.H., and R.J.D.; Visualization and Writing, J.M.R., M.J.S., K.M.R., and R.J.D.
HHS Public Access
Author manuscript
Cell. Author manuscript; available in PMC 2018 November 30.
Published in final edited form as:
Cell. 2017 November 30; 171(6): 1326–1339.e14. doi:10.1016/j.cell.2017.10.016.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A cell’s repertoire of SCF ubiquitin ligases, which target proteins for degradation, is directly 
shaped by the substrates present.
Introduction
Regulation of protein stability and function by the ubiquitin-proteasome system (UPS) 
influences diverse aspects of eukaryotic biology. The ubiquitylation cascade involves three 
enzymes – E1, E2, and E3 – that work successively to attach ubiquitin to substrate proteins, 
which results in altered protein function or proteasomal degradation (Dye and Schulman, 
2007; Husnjak and Dikic, 2012). Substrate specificity is conferred by E3 ubiquitin ligases, 
of which the SCF family of cullin–RING ubiquitin ligases (CRLs) is among the most 
intensively studied (Deshaies and Joazeiro, 2009; Skaar et al., 2013).
Each SCF comprises a Cul1•Rbx1 catalytic core bound to a variable F-box protein 
(FBP)•Skp1 substrate recognition (SR) module (Feldman et al., 1997; Kamura et al., 1999; 
Ohta et al., 1999; Seol et al., 1999; Skowyra et al., 1997). The human genome encodes ≥69 
FBPs, alluding to the possibility of 69 distinct SCFs, though only 42 are confirmed and most 
of these complexes remain uncharacterized (Jin et al., 2004; Lee et al., 2011). Due to their 
substrate specificity, SCF ligases represent promising targets for therapeutic manipulation. 
Gain or loss of function of specific SCFs is directly implicated in tumorigenesis and other 
diseases (Nakayama and Nakayama, 2006; Skaar et al., 2014).
The cumulative functional output and physiological impact of all SCFs at any given time is 
presumably determined by the extant repertoire of SCFs. This repertoire can change 
dramatically as cells differentiate, as shown for CRL3 complexes (Werner et al., 2015). 
Therefore, a key unanswered question is, what mechanism(s) sculpts the repertoire of SCF 
and other CRLs? The prevailing model, which is based on biochemical studies, predicts that 
SR modules bind tightly to Cul1, but their interaction is rendered dynamic by Cand1, which 
is an SR exchange factor (SREF) that equilibrates Cul1 with the cellular pool of SR modules 
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(Pierce et al., 2013; Wu et al., 2013; Zemla et al., 2013). This exchange is controlled by 
Nedd8 conjugation: when substrate is bound to SCF, preservation of Nedd8 modification on 
Cul1 stimulates substrate ubiquitination and blocks Cand1 from dislodging the SR module. 
When substrate dissociates, Nedd8 is removed by isopeptidase Cop9-Signalosome (CSN), 
allowing Cand1 to catalyze exchange of the SR module (Bornstein et al., 2006; Cavadini et 
al., 2016; Emberley et al., 2012; Enchev et al., 2012; Fischer et al., 2011; Pierce et al., 2013; 
Schmidt et al., 2009; Zemla et al., 2013). This model predicts that substrate availability 
governs the cellular landscape of SCF enzymes.
This model, though attractive, is based primarily on in vitro biochemical studies with a few 
FBPs (Pierce et al., 2013). Moreover, blocking Nedd8 conjugation has no effect on SCF 
assembly, suggesting either that SCF ubiquitin ligases are not undergoing cycles of dynamic 
assembly/disassembly in cells or there exist alternative mechanisms that regulate dynamics 
in vivo (Bennett et al., 2010; Lee et al., 2011). Meanwhile, Cand1 depletion yields 
conflicting results, with some studies reporting no effect (Bennett et al., 2010) and others 
reporting a change in the SCF repertoire (Pierce et al., 2013; Wu et al., 2013). However, we 
demonstrate here that prior analyses of cellular SCF complexes were confounded by rapid 
exchange of SR modules during immunoprecipitation from cell lysate, and this would affect 
prior results and their interpretation in ways that are difficult to predict. Here, we developed 
a multiplex affinity purification-selected reaction monitoring (SRM) platform to query the 
assembly state of SR modules in human cells. By suppressing exchange, we show that the 
cellular SCF repertoire is in a state of disequilibrium that is sustained by Nedd8 conjugation 
and Cand proteins, and is modulated by substrate availability.
Results
Post-cell lysis equilibration of SCF complexes is extremely rapid
Based on our finding that Cand1 is a potent SREF (Pierce et al., 2013), we investigated 
whether Cand1 might mediate exchange of SR modules in cell lysate during a conventional 
immunoprecipitation. To evaluate this, we developed a SILAC-based SRM exchange assay 
that enabled us to monitor the levels of all SCF regulators and subunits (Table S1A). In 
parallel, we used CRISPR technology to engineer HEK293 cells such that endogenous Cul1 
was tagged with 3XFLAG at its N-terminus (Fig. S1A–D). Insertion of the 3xFLAG tag did 
not affect cell proliferation or steady-state levels of cyclin E, an SCFFBXW7 substrate (Fig. 
S1D–E) (Koepp et al., 2001; Strohmaier et al., 2001). The rationale for developing this cell 
line is that it enabled rapid and efficient immunodepletion of Cul1 (Fig. S1F) while avoiding 
artifacts that are inherent to overexpression of scaffold proteins (Gibson et al., 2013). To 
evaluate exchange in cell lysate, we mixed isotopically light-labeled HEK2933xFLAG-Cul1 
cells 1:1 with heavy-labeled untagged HEK293 cells, lysed the cells in native lysis buffer 
that blocks the Nedd8 cycle (Fig. S1G) and allows complete extraction of 3xFLAGCul1 into 
the soluble fraction (Fig. S1H), immunoprecipitated 3xFLAGCul1, and measured the H:L 
ratio of co-precipitating factors (Fig. 1A). We observed pervasive equilibration of FBPs, 
Skp1, Cand1, and CSN during immunoprecipitation, whereas essentially no exchange was 
observed for Cul1•Rbx1 (Figs. 1B–C, S2A–C; Table S2A). Although exchange increased 
over time, it was substantial even in 10’ immunoprecipitations. We surmised that this robust 
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equilibration was due to Cand1. Because Nedd8 shields Cul1 from Cand1-mediated 
exchange (Pierce et al., 2013), blocking Nedd8 conjugation should increase FBP exchange. 
To test this idea, HEK2933xFLAG-Cul1 cells were pretreated with the Nedd8 activating 
enzyme (NAE) inhibitor, MLN4924 (Fig. S1I) (Brownell et al., 2010; Soucy et al., 2009) 
and subjected to SILAC-SRM analysis. MLN4924 exacerbated exchange for all FBPs (Figs. 
1B, S2A–C) but had a much greater effect on some FBPs than others (e.g. FBXO11 vs. 
FBXO7), indicating that the wide variation in FBP exchange was due in part to differential 
neddylation of the respective SCF complexes (Fig. S2D). Indeed, the FBPs most refractory 
to exchange (FBXO9 and FBXO11) exhibited near-median exchange upon MLN4924 
treatment (Figs. 1B–C, S2A–C).
To further explore the idea that SREF activity mediates FBP exchange, we used CRISPR 
technology to knockout both Cand1 and its paralog Cand2 in HEK2933xFLAG-Cul1 cells to 
generate tagged double-knockout (DKO) cells (Fig. S1C–E) and subjected these cells to our 
SILAC-SRM exchange assay (Fig. 2A). In the absence of Cand1/2, exchange in cell lysate 
was significantly suppressed for Skp1 and all FBPs, except FBXO5/Emi1 (Figs. 2B–C, 
S2E–G; Table S2B). Exchange was restored back to DKO lysate upon mixing with untagged 
wild type (Wt) lysate. Moreover, spiking recombinant Cand1 (rCand1) into DKO lysate 
displaced Skp1 and FBPs from endogenous Cul1 (Fig. 2D). These data demonstrate that 
Cand1/2-dependent post-lysis exchange has a major but previously unappreciated effect on 
SCF and probably other CRLs.
Post-lysis exchange of FBPs is suppressed by addition of a molecular sponge
To investigate the repertoire of cellular SCFs and how it changes in response to 
environmental or genetic perturbations, it was essential to suppress exchange in cell lysate. 
Our prior work established that binary SR•Cul1 and Cul1•Cand1 complexes are 
exceptionally stable, whereas ternary SR•Cul1•Cand1 complexes dissociate ~106 fold more 
rapidly (Pierce et al., 2013). We hypothesized that a large excess of recombinant 
Cul1•GSTRbx1 (rCul1GSTRbx1) added to lysis buffer prior to cell lysis would function like a 
molecular sponge and soak up free Cand1/2 and any SR module not bound to Cul1 to form 
stable binary complexes, and thus prevent endogenous Cul1 from forming metastable 
ternary complexes in lysate that underlie exchange (Fig. 3A). Indeed, this was the case. By 
performing a 20’ immunoprecipitation in the presence of rCul1GSTRbx1 (Fig. S3A), 
exchange of Skp1, Cand1, and all FBPs, except FBXO5/Emi1 was greatly curbed (Figs. 3B–
C, S3B–D; Table S2C). Importantly, we also show that excess rCul1GSTRbx1 suppresses the 
ability of endogenous Cul1 to form new SCF complexes in the lysate (Fig. S3E).
A potential concern of adding a large bolus of rCul1GSTRbx1 to cell lysate is that it would 
compete off SRs and Cand1 that were bound to endogenous 3xFLAGCul1. To address this 
issue, we immunoprecipitated 3xFLAGCul1 from Wt cell lysate in the presence or absence of 
rCul1GSTRbx1. Contrary to conventional expectation, rCul1GSTRbx1 increased the yield of 
Skp1, Skp2, and FBXO7 bound to endogenous 3xFLAGCul1, whereas recovery of Cand1 was 
modestly decreased (Fig. S3F). We also evaluated this concern by SRM analysis 
of 3xFLAGCul1 immunoprecipitates from DKO cells to monitor assembly of all FBPs in the 
absence of Cand1/2-mediated exchange. Excess rCul1GSTRbx1 sequestered only CSN from 
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endogenous 3xFLAGCul1 (Fig. S3G–H), which is consistent with the fast koff of CSN from 
Cul1 (Mosadeghi et al., 2016). This result was also confirmed by IP/Western blot in the 
presence of MLN4924, which removes any influence of neddylation (Fig. S3I). Thus, 
addition of rCul1GSTRbx1 preserves the in vivo cellular landscape of SCF ligases by 
titrating out Cand1/2 and thereby preventing SR exchange. This result also suggests that the 
FBXW7•Skp1 studied previously (Pierce et al., 2013) is not unusual in terms of its 
interaction with Cul1•Rbx1, and that the koff of SR modules from SCF in the absence of 
Cand1 is very slow for all FBPs.
Analysis of endogenous Cul1 in the absence of exchange is necessary to observe 
regulation of the SCF landscape
Extensive exchange of SR modules during the course of a Cul1 immunoprecipitation has 
major implications for measuring dynamic changes in the SCF network. Any non-
equilibrium state that existed in vivo may be lost during immunoprecipitation. Biochemical 
analyses of purified proteins predict that inhibiting Cul1 neddylation should promote net 
disassembly of SR modules from Cul1 because Nedd8 conjugation blocks Cand1 from 
binding Cul1 (Pierce et al., 2013). Conversely, depletion of Cand1 should favor assembly of 
SRs with Cul1. Paradoxically, prior studies concluded that inhibition of NAE had no 
significant impact on the cellular landscape of SCF ligases (Bennett et al., 2010; Lee et al., 
2011). On the other hand, conflicting results were reported for depletion of Cand1 (Bennett 
et al., 2010; Pierce et al., 2013; Wu et al., 2013). However, these studies were performed 
with lysates that contained Cand1, and thus they may have been monitoring SCF complexes 
formed in cell lysate during immunoprecipitation. Since we could now limit post-lysis 
exchange with rCul1GSTRbx1, we re-examined whether MLN4924 treatment promoted net 
disassembly of SCF complexes. The Cul1 assembly states of Skp2 and βTrCP were 
monitored as surrogates for fast and slow exchanging FBPs, respectively (Fig. 1C). 
MLN4924 treatment strongly decreased assembly of Skp2, βTrCP, and Skp1 
with 3xFLAGCul1 when the lysis buffer contained rCul1GSTRbx1 (Fig. 4A). By contrast, 
MLN4924 had less or no effect on FBP assembly with Cul1 when immunoprecipitations 
were carried out for 3 h in the absence of rCul1GSTRbx1.
Another limitation of prior studies is that the human SCF repertoire was studied by stably 
integrating an additional copy of tagged Cul1. Overexpression of scaffold proteins is known 
to create potential artifacts (Gibson et al., 2013). To investigate whether extra Cul1 blunts 
the effect of MLN4924 treatment, we constructed a Flp-In cell line in which 3xFLAGCul1 
expression was approximately 5-fold above endogenous Cul1 levels (Fig. 4B). Indeed, 
transgenic 3xFLAGCul1 completely abolished the effect of MLN4924 (Fig. 4B). This can be 
understood in light of the fact that endogenous levels of Skp1 are in modest excess over 
Cul1 (Fig. S5A and (Bennett et al., 2010)). These data demonstrate that analyzing 
endogenous Cul1 under conditions where FBP exchange is suppressed is necessary to 
observe proper regulation of SCF assembly.
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Nedd8 conjugation and Cand1/2-mediated exchange sustain a non-equilibrium pool of SCF 
ubiquitin ligases
Using the methods described above, we set out to examine the effect of perturbing Cand1/2 
activity and Nedd8 conjugation on the cellular SCF repertoire. Specifically, we sought to 
measure the percent of every SR module that is bound to Cul1. However, this required us to 
quantify SRs that were not bound to Cul1. Preliminary studies on the flow-through from 
a 3xFLAGCul1 immunoprecipitation revealed that only 6 FBPs could be reliably detected via 
SRM (data not shown). However, we hypothesized that the rCul1GSTRbx1 that was added to 
suppress exchange would sequester all free SR modules and other Cul1-binding proteins and 
that recovery of rCul1GSTRbx1 after 3xFLAGCul1 immunoprecipitation would enrich for 
these proteins sufficiently to allow their detection by SRM. Indeed, Western blot analysis 
(Fig. S3J) revealed that pull-down of rCul1GSTRbx1 depleted all Skp1 and Cand1 and about 
half of the CSN5 that was in the flow-through of the 3xFLAGCul1 immunoprecipitation. The 
remaining CSN5 might be bound to other CRL complexes. Because all FBPs are presumed 
bound to Skp1 (with perhaps one or two exceptions; (Reiterer et al., 2017; Yen et al., 2012)), 
complete depletion of Skp1 implied that all assembly-competent FBPs not bound to 
endogenous 3xFLAGCul1 were retrieved by rCul1GSTRbx1. These results indicate that, with 
the exception of CSN, we could accurately determine the percentages of all Cul1-binding 
proteins that were associated with Cul1 in cells by assessing their relative amounts in 
the 3xFLAGCul1 and rCul1GSTRbx1 pull-downs.
Application of our quantification methodology to determine the assembly state of FBPs in 
unperturbed HEK2933xFLAG-Cul1 cells revealed two striking and unexpected observations. 
First, FBPs exhibited remarkable range (0–70%) in their percent association 
with 3xFLAGCul1. This dramatic variation suggested that FBPs were not in equilibrium 
with 3xFLAGCul1 (Figs. 5A, S4A–C; Table S2D), hinting at the existence of cellular 
mechanisms to sustain a non-equilibrium pool of SCFs. Second, most FBPs exhibited 
inefficient association with endogenous 3xFLAGCul1. Of those FBPs that were quantified, 
only 1/5 exhibited greater than 30% binding to 3xFLAGCul1, and more than 1/4 (27%) 
showed no detectable association (Figs. 5A, S4A–C). This was consistent with Skp1 being 
present in 4-fold molar excess of Cul1 (Fig. S5A). Thus, despite the prevailing assumption 
that FBPs are assembled into SCF complexes, with the exception of FBXO11 and FBXL14 
more than half of the molecules of all 47 other quantified FBPs were not bound 
to 3xFLAGCul1 in HEK2933xFLAG-Cul1 cells. The third major conclusion from this 
experiment is that nearly 30% of all known FBPs were not detected in either the 3xFLAGCul1 
or rCul1GSTRbx1 pull-downs, suggesting they were either poorly expressed or were not 
competent to bind Cul1. Consistent with this observation, several of these FBPs are tissue-
restricted (Ye et al., 2007), expressed early during development (Okita et al., 2007), or 
dependent on small molecules for stability (Salahudeen et al., 2009).
Now that we had successfully defined the assembly status of all FBPs in 
HEK2933xFLAG-Cul1 cells, we sought to investigate how various perturbations altered the 
assembly of different FBPs. In contrast to prior reports (Bennett et al., 2010; Lee et al., 
2011), inhibition of Cul1 neddylation shifted FBPs towards an unassembled state (Figs. 5A, 
S4D–F) whereas association of Cand1/2 increased (Figs. 5B; S4F–G). Meanwhile, double 
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knockout of Cand1/2 had the opposite effect (Figs. 5A–B, S4D–G). A core prediction of the 
SCF assembly model that emerged from biochemical studies is that the SREF activity of 
Cand1 is regulated by cullin neddylation (Pierce et al., 2013). If this is correct, the disruption 
of SCF complexes by MLN4924 should be dependent on Cand1/2. Indeed, MLN4924 had 
no significant effect on FBP assembly in DKO cells (Figs 5A, S4E). These striking results 
are at odds with claims that Cand1 depletion has no effect on SCF assembly in human cells 
(Bennett et al., 2010) and Cand1 deletion causes a net reduction in SCF complexes in fission 
yeast (Wu et al., 2013). Two factors may account for the former discrepancy. First, 
knockdown of Cand1 results in elevated Cand2 binding to Cul1 (X. Liu, unpublished data). 
Second, elimination of Cand1 function in C. elegans requires its depletion beyond the level 
reported by Bennett et al. (Bosu et al., 2010).
Although the overall trends in FBP behavior in response to MLN4924 or Cand1/2 knockout 
were clear and striking, there was considerable unexplained granularity in the data. For 
example, FBXO44 assembly increased in cells treated with MLN4924 whereas several FBPs 
continued to show little or no assembly with Cul1 in DKO cells, at least one of which 
(FBXL16) does not appear to form an SCF complex (Honarpour et al., 2014). These 
observations highlight how SRM studies can open up new, unanticipated lines of inquiry.
To determine what percent of Cul1 was occupied by SR modules or Cand1/2 under various 
conditions, we determined the absolute concentrations of total and assembled pools of Skp1, 
Cand1/2, Cul1, and other SCF components in HEK293 (Wt and DKO cells) and 293T cells 
using SRM (Fig. S5A, D–F). There are some important discrepancies between values 
published by Bennett et al. (2010) and those reported here, which we discuss in the methods 
section. 3xFLAGCul1 was shared equally between Cand1 and Skp1 in HEK2933xFLAG-Cul1 
cells. Meanwhile, Cand2 occupied less than 0.25% of Cul1 suggesting that it either has very 
little impact on SCF assembly in unperturbed HEK293 cells or is limited to a specific 
cellular locale (Figs. 5B, S5B). MLN4924 treatment decreased the Skp1 occupancy of Cul1 
by 50%, while the Cand1 occupancy increased by ~37% (Fig. 5B); the latter figure was 
presumably constrained by the excess of Cul1-Cul5 (~2,050 nM) over Cand1 (~1210 nM). 
MLN4924 treatment increased the Cand2 occupancy of Cul1 dramatically, although it still 
only occupied less than 1% of Cul1. In the absence of Cand1/2, Skp1 occupied 100% of 
endogenous Cul1.
To gain further insight into the landscape of SCF enzymes, we measured the cellular 
concentration of 10 FBPs in both Wt and DKO HEK2933xFLAG-Cul1 cells (Fig. S5B). The 
FBPs selected were those that gave the strongest signals above background in SRM analyses 
of total cell lysate with unpurified peptides. The differences in FBP concentration between 
the 2 cell types were all within 2-fold, except for FBXO11 (~3 fold higher in DKO cells; 
Fig. S5B). Using the measured concentrations of these FBPs and Cul1, we calculated the 
percent of Cul1 which each FBP occupies in both Wt and DKO cells ± MLN4924 (Fig. 5C). 
Although FBXO11 was the FBP that assembled most efficiently with Cul1 (Fig. 5A), 
SCFFBXO11 was not the most abundant SCF complex; that distinction, at least in 293 cells, 
went to SCFFBXO33 (Fig. 5C), about which little is known. In keeping with the idea that 
formation of SCF complexes is regulated, there was no correlation between the cellular 
concentration of FBPs and their percent assembly with Cul1 in Wt or DKO 293 cells (Fig. 
Reitsma et al. Page 7
Cell. Author manuscript; available in PMC 2018 November 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
S5C). Notably, in Wt cells these 10 FBPs accounted for 56% of total SCF ligases (Fig. 5C). 
Upon treatment with MLN4924 all 10 of these SCF complexes decreased in amount, 
whereas most of them were increased in DKO cells, mirroring the changes in percent 
assembly of FBPs (Fig. 5A). Together, these provide the most detailed and quantitative 
picture reported to date of the repertoire of FBPs and SCF complexes in a human cell.
Substrate drives assembly of SCF complexes
If Nedd8 conjugation and Cand1/2 jointly sustain a non-equilibrium population of SCF 
complexes, how are their actions controlled so that the SCF repertoire matches cellular 
demand? Biochemical data suggest that substrate may be the key, because bound substrate 
represses deneddylation, which should stabilize a CRL complex against exchange (Emberley 
et al., 2012; Enchev et al., 2012; Fischer et al., 2011; Pierce et al., 2013). We next sought to 
test this idea in a physiological context. Previous work demonstrated that EGF induces the 
degradation of phoso-AKT via SCFSKP2 and this corresponded to increased co-
immunoprecipitation of overexpressed Skp2 with Cul1 (Chan et al., 2012). Therefore, we 
investigated whether EGF treatment influences assembly of the endogenous Skp2 and Cul1 
proteins. Serum-starved Wt 3xFLAGCul1 cells were treated ± EGF for 15 minutes 
and 3xFLAGCul1 immunoprecipitated from the cells was analyzed via SRM. We observed 
that EGF reproducibly increased Cul1 assembly of not only Skp2, but also βTrCP1 and 
FBXL18 by >2-fold (Fig 6A; Table S2E), suggesting roles for the latter two proteins in the 
EGF response. Indeed, FBXL18 has been linked to EGF signaling (Zhang et al., 2017). 
Western blot analysis revealed that DKO cells had a higher resting level of p-AKT and 
Skp2•Cul1 complex, but that the EGF-induced assembly of Skp2 with Cul1 was dependent 
on Cand1/2 and Nedd8 conjugation (Fig. S6A, C–D). Consistent with this, the half-life of p-
AKT was increased by ~3-fold in DKO cells (Fig. S6B). We additionally verified that EGF 
enhances formation of SCFFBXL18 in a Cand1/2 and Nedd8 dependent manner (Fig. S6D) 
pointing to the intriguing possibility that regulated assembly can be used to discover new 
functions for FBPs.
We further pursued this idea by examining relative assembly of SCF complexes at the DNA 
replication and spindle checkpoints. (Figs. 6B, S6E). Notably, 8 FBPs exhibited >2-fold 
change in relative assembly with Cul1 at the two arrest points (Figs. 6B, S6F; Table S2F). Of 
the 5 FBPs that exhibited increased assembly in metaphase arrest, cyclin F was previously 
linked to centrosome duplication and maintenance of dNTP pools during G2 phase of the 
cell cycle (D’Angiolella et al., 2012; D’Angiolella et al., 2010). Meanwhile of the 3 FBPs 
that exhibited increased assembly with Cul1 in S phase relative to metaphase arrest (Figs. 
6B, S6F; Table S2F), FBXW7 and Skp2 are functionally linked to G1/S phase progression 
(Carrano et al., 1999; Koepp et al., 2001; Strohmaier et al., 2001; Sutterluty et al., 1999; 
Zhang et al., 1995).
Finally, we employed the SRM approach to quantify percent assembly of SCF enzymes 
upon induction of DNA damage with etoposide (Fig. S7A). This revealed substantial 
variation in percent assembly of a few FBPs (Figs. 6C, S7B–E, Table S2G). Notably, the 
FBP that showed the largest magnitude change, FBXO6 (Figs. 6C–D, S7F), was previously 
implicated in the recovery from DNA damage (Zhang et al., 2009). Enhanced formation of 
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SCFFBXO6 was observed within 3 hrs of etoposide addition (Fig. 6D). In addition to 
FBXO6, FBXO9 also showed strong DNA damage-induced assembly with Cul1 (Figs. 6C, 
S7G–H), suggesting that it too may function in the DNA damage response. Taken together, 
these experiments show that three distinct perturbations induce assembly of SCF complexes 
that have already been linked to each perturbation, suggesting that the substrate-induced 
stabilization of particular SCF complexes can be exploited to discover new functions for 
FBPs. Our results suggest unanticipated functions for several FBPs, including βTrCP1 in 
EGF signaling and FBXO9 in DNA damage response.
A potential confounding factor with the experiments described above, is that the perturbation 
employed could influence not only substrate, but perhaps the enzyme itself. For example, 
induced assembly of Skp2 with Cul1 upon addition of EGF could be triggered not only by 
formation of p-AKT substrate but possibly by EGF-induced modification of Skp2. To 
definitively establish that substrate is sufficient to drive formation of an SCF complex, we 
used a bio-orthogonal signal to generate substrate. We turned to the auxin-dependent 
degradation of proteins bearing an auxin-inducible degron (AID) because this process: (i) is 
well characterized and depends on an SCF complex; (ii) has been successfully transplanted 
into human cells, where auxin has no known biological effect. We engineered Wt and 
DKO 3xFLAGCul1 cells to express the rice FBP Tir1 tagged with a 9xMyc epitope and its 
engineered substrate H2BAID-YFP (Holland et al., 2012). Like endogenous FBPs, Tir19xMyc 
exhibited increased assembly with 3xFLAGCul1 in DKO cells (Tir1 occupied 2.2% and 9.5% 
of 3xFLAGCul1 in Wt and DKO cells, respectively; Fig. 7A). Consistent with Holland et al. 
(2012), H2BAID-YFP was degraded with a t1/2 of 45’ in Wt cells. This increased to 82’ in 
DKO cells despite the elevated assembly of Tir19xMyc with 3xFLAGCul1 (Fig. 7B). To 
evaluate if substrate promotes formation of SCFTir1, we induced expression of H2BAID-YFP 
with tetracycline and then treated with auxin to initiate H2BAID-YFP degradation, followed 
by cell lysis and immunoprecipitation of 3xFLAGCul1. Auxin treatment increased assembly 
of Tir19xMyc with 3xFLAGCul1 by ~3-fold (Fig. 7C–E). This effect was both fast and 
specific: enhanced assembly was observed in as little as 10 min (Fig. 7C), and auxin had no 
effect on 3xFLAGCul1 association with the FBPs Skp2 (Fig. 7C–E), β-TrCP (Fig. 7E), or 
FBXO7 (Figs. 7C–D). To evaluate the role of Nedd8 conjugation and Cand1/2-mediated 
exchange in induced formation of SCFTir1 complexes, we repeated the experiment in Wt and 
DKO cells treated with MLN4924 (Fig. 7E–F). Strikingly, auxin failed to enhance formation 
of SCFTir1 in either case. Consistent with the idea that substrate enhances accumulation of 
its cognate SCF complex by protecting it from deneddylation, auxin increased the percent 
neddylation of Cul1 bound to Tir1 (Fig. 7F).
Discussion
In this study, we developed a multiplex affinity purification-SRM mass spectrometry assay 
to measure SCF ubiquitin ligase assembly in cells and identified an important but previously 
unappreciated limitation of prior studies that investigated SCF assembly (Bennett et al., 
2010; Chua et al., 2011; Lee et al., 2011; Pierce et al., 2013; Wu et al., 2013; Yumimoto et 
al., 2013). The SR exchange factor Cand1 catalyzes unexpectedly rapid and pervasive 
exchange of SR modules during the course of a conventional immunoprecipitation, such that 
the sample that is analyzed is comprised largely of complexes that formed during in vitro 
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manipulations. Because of the exchange that occurs post-cell lysis, non-equilibrium steady-
states that exist in cells are scrambled upon generation of a homogeneous lysate. We show 
that post-lysis SR exchange, as well as modest overexpression of Cul1 scaffold, obscure the 
profound effect of MLN4924 treatment on SCF assembly. It is unclear whether post-lysis SR 
exchange is a problem for other CRL complexes, but we suspect that it is considering that 
Cand1 binds other cullins (Bennett et al., 2010; Chua et al., 2011; Liu et al., 2002; Min et 
al., 2003; Zheng et al., 2002). Although SR exchange is a facilitated process, in the case of 
the p97 network rapid equilibration of cofactors is mediated by their high intrinsic kon and 
koff (Xue et al., 2016). This problem is likely to be widespread and may affect other 
heteromeric enzymes that undergo dynamic remodeling, like protein phosphatase 2A (Kong 
et al., 2009).
To suppress the rampant Cand1/2-dependent exchange of SR modules in cell lysate, we used 
rCul1GSTRbx1 as a molecular sponge to ‘soak-up’ free Cand1/2 and SR modules by 
recruiting them into stable SR•Cul1•GSTRbx1 and Cul1• GSTRbx1•Cand1 complexes. The 
molecular sponge not only limits post-lysis SR exchange, but it also enables independent 
recovery and quantification of both assembled and free pools of Cul1-binding proteins, 
thereby revealing the composition of the ‘SCFome’.
Using the methodology developed here, we report two unexpected findings regarding 
assembly of FBPs into SCF complexes. First, we show that the steady-state repertoire of 
SCF ubiquitin ligases is in disequilibrium as different FBPs display massive variation in 
efficiency of binding to Cul1 (ranging from 0–70%). Second, we show that FBP assembly 
with Cul1 is inefficient; greater than half of all FBPs exhibit ≤10% assembly into SCF 
complexes. This low binding is a consequence of two factors: (i) Skp1 is in 4-fold molar 
excess over Cul1, and (ii) nearly half of the Cul1 pool is occupied by Cand1. The substantial 
imbalance between Cul1 and SRs underscores a need for a mechanism to remodel the 
repertoire of SCF complexes to allow cells to adapt to different physiological states. 
Deconjugation of Nedd8 from Cul1 and subsequent Cand1/2-mediated exchange together 
serve as the driving force to sustain dynamic reshuffling of SCF complexes in cells. 
Inhibition of Nedd8 conjugation shifts FBPs towards net disassembly. By contrast, 
elimination of the Cand1/2 proteins has the opposite effect. Importantly, the disassembly of 
FBPs caused by MLN4924 is driven by Cand1/2 activities because MLN4924 has little 
effect on the SCF repertoire in cells lacking these proteins.
In addition to a mechanism to remodel their SCF complexes, cells need to regulate 
remodeling to guide it in an advantageous direction. How does this happen? To avoid 
confounding effects that might arise from using an endogenous regulatory pathway that 
could impinge on both enzyme and substrate, we employed a ‘synthetic biology’ approach 
that capitalizes on a heterologous rice ubiquitylation pathway transplanted into 293 cells. 
With this system we demonstrate that addition of auxin stimulates binding of the auxin-
dependent model substrate H2BAID-YFP to its cognate rice FBP Tir1, which in turn binds 
endogenous human Cul1 to form an SCF complex. Crucially, auxin-induced formation of 
SCFTir1 was dependent on both Cand1/2 activity and Nedd8 conjugation. More generally, 
this observation implies that SCF complexes mobilized in response to a particular signal or 
stress are reacting to substrates generated in that context, which could point the way to new 
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functions for FBPs. Indeed, we demonstrate in three separate examples (+EGF, cell cycle 
arrest, and DNA damage induction) that signaling events drive the formation of a specific 
SCF complexes, some of which have already been implicated in these processes, but 
including others which have not. For EGF signaling, we demonstrated that mitogen-induced 
formation of SCFSkp2 and SCFFBXL18 are dependent on Cand-mediated exchange and 
Nedd8 conjugation
Our studies indicate that the cellular landscape of SCF ligases resembles a “Just in Time” 
system, which in business is a strategy to increase efficiency and decrease waste by only 
receiving goods for production as they are needed. Similarly, a cell preferentially 
accumulates a particular SCF complex to high levels when its substrate is present. It will be 
interesting to see how these events are coordinated in time and space, and whether other 
CRLs are governed by similar principles.
Star Methods
Contact for Reagent and Resource Sharing
Further information and reagent requests may be directed to the lead contact Raymond J. 
Deshaies (deshaies@caltech.edu).
Experimental Model and Subject Details
Human Cell Lines—All cell lines were authenticated by Laragen Inc. using the Promega 
PowerPlex 16 system and periodically tested for mycoplasma contamination.
Flp-In T-REX 293 Cells—Cells were maintained in DMEM supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 2 mM glutamine, and penicillin-streptomycin. The 
Cand1/2 knockout Flp-In T-REx HEK293 cells were developed using CRISPR technology 
and described in an accompanying manuscript. SILAC labeling was carried out in SILAC 
DMEM containing 10% dialyzed FBS and 13C615N2-lysine and 13C6-arginine.
293FT and 293T/17 Cells—Cells were maintained in DMEM supplemented with 10% 
heat-inactivated fetal bovine serum (FBS), 2 mM glutamine, and penicillin-streptomycin.
Method Details
Materials and plasmids—MLN4924, 1,10 phenanthroline (oPT), Etoposide, 
Nocodazole, and Cisplatin were dissolved in dimethyl sulfoxide (DMSO). Hydroxyurea was 
dissolved in water. Human recombinant EGF protein was dissolved in 0.1% FBS in PBS.
The lentiviral backbone pCDH-EF1-MCS-IRES-NEO was used to direct the expression 
of HAFBXO6 and osTir19xMyc. The osTir19xMyc backbone sequence and the H2BAID-YFP 
construct was a kind gift from Dr. Don Cleveland and is described in (Holland et al., 2012). 
The pX330-U6-Chimeric BB-CBh-hSpCas9 plasmid (Cong et al., 2013) was used to create 
Cul1 epitope-tagged cell lines. pCR-Blunt II-TOPO was used to create the CRISPR donor 
construct.
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Generation of stable cell lines—Lentivirus were generated as described (Nguyen et al., 
2016). Briefly, osTir19xMyc and HAFBXO6 lentiviral constructs were cotransfected with 
packaging (psPAX2) and enveloping (pMD.2G) plasmids into 293FT cells using Fugene 
HD. Virus-containing supernatants were harvested at 48 and 72 hrs after transfection. The 
viral titer was determined using Lenti-X GoStix. 3xFLAGCul1 Wt and DKO (osTir19xMyc 
only) HEK293 cells were infected at a multiplicity of infection of 2.0. Expression of the 
proteins in all cells was verified by immunofluorescence.
Targeted integration of constructs into 293 Flp-In T-REx cells—Targeted 
integration of H2BAID-YFP and FLAGCul1 coding sequences into the Flp-In site was carried 
out as previously described (Holland et al., 2012; Pierce et al., 2013). Briefly, 293 Flp-in T-
Rex cells were cotransfected with pcDNA.5/FRT/TO based vectors and pOG44 Flp-
Recombinase using Lipofectamine 3000. One day following transfection, cells were treated 
with 100 µg/ml Hygromycin to select for cells with successful integration. To induce protein 
expression, cells were treated with 1 µg/mL tetracycline.
Affinity-Purification for SRM and Western blot analysis—Approximately 25 µl of 
packed 3xFLAGCul1 HEK293 cells were lysed in 500 µl Pierce IP lysis buffer containing 1x 
protease inhibitor, 1 µM MLN4924, and 2 mM oPT. When determining percent bound to 
Cul1 or suppressing post-cell lysis exchange, rCul1GSTRbx1 was added to the IP buffer at 
100x endogenous levels (~1.5 µM) prior to cell lysis (Bennett et al., 2010). Cell lysates were 
briefly sonicated (10 seconds; 1 second ON/OFF; 10% of maximum amplitude using 
Branson Digital Sonifier) and cleared by centrifugation at 14,100 RPM for 2-minutes at 4°C. 
Analysis of the insoluble pellet confirmed essentially complete solubilization of 3xFLAGCul1 
(Fig. S1H). Approximately 3-minutes elapsed from addition of lysis buffer to the 
immunoprecipitation step. The soluble fraction was transferred to 50 µl of anti-FLAG 
affinity gel and immunoprecipitated for the indicated amount of time. The anti-FLAG 
affinity gel was washed 2x with IP lysis buffer, 1x with lysis buffer lacking detergent, and 3x 
with 100 mM Tris (pH 8.0). The flow-through was transferred to 300 µl of pack glutathione 
sepharose 4B beads plus 500 µl more lysis buffer and incubated for 2 hrs at 4°C. Beads were 
washed as described above. For SRM analysis, protein was eluted from anti-FLAG and 
glutathione beads with 10% ammonium hydroxide. Samples were lyophilized and protein 
was digested according to (Lee et al., 2011). For Western blot analysis, samples were eluted 
in 2x SDS loading buffer. Quantification of Western blots was performed using 
ImageStudioLite software.
Effects of mitogen signaling, cell cycle arrest, and DNA damage on the 
SCFome—To assess DNA damage-dependent changes in the SCFome, 
HEK2933xFLAGCul1 cells (70% confluency) were treated with DMSO or 50 µM etoposide 
for 16 hrs. To assess cell cycle-dependent changes in the SCFome, HEK2933xFLAGCul1 
cells were treated with either 100 ng/ml of nocodazole or 5 mM hydroxyurea for 16 hrs 
(Bengoechea-Alonso et al., 2005). To assess EGF-dependent changes in the SCFome 
HEK2933xFLAGCul1 cells were serum starved for 18 hrs and then EGF was added to cells at 
50 ng/ml (Chan et al., 2012). Cells were lysed and prepared for SRM analysis or Western 
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blot as described above. Prior to injection, samples were spiked with heavy synthetic peptide 
standards, which we used to normalize between replicates.
Epitope tagging using CRISPR/Cas9—pX330 was constructed as described in (Cong 
et al., 2013) using the Cul1 targeting sequences (Fig. S1A). Efficient Cas9 cleavage of the 
Cul1 targeting site was assessed using a Surveyor Mutation Detection Kit (Integrated DNA 
Technologies) (Fig. S1B). To assemble the CRISPR donor sequence, we synthesized gBlock 
DNA (Integrated DNA Technologies) sequences corresponding to that shown in Fig. S1A 
and then assembled into one amplicon using Gibson Assembly. The Cul1 homology arms 
were 500 bp in length. The donor sequence was cloned into a vector (pCR II- Blunt-Topo) 
that does not contain a promoter that drives transcription. HEK293 cells (Wt and DKO) were 
transfected with the Cul1-targeting CRISPR plasmid and the donor plasmid using 
Lipofectamine 3000 at a 3:1 molar ratio, respectively. After 24 hrs, single cells were seeded 
into 96-well plates. Once clones reached confluency, they were screened for homologous 
insertion of the 3xFLAG tag at the N-terminus of Cul1 using PCR and Western blot (Fig. 
S1C–D). Cell morphology, cell growth (Fig. 1SE), and Cul1 neddylation (Fig. 1SD) were 
compared to parental cells to ensure that the epitope-tagging did not affect cell physiology.
Purified recombinant proteins—Cul1GSTRbx1, UBC12, DCN1, Skp2-Skp1, and 
Nedd8 were purified as described in (Li et al., 2005; Saha and Deshaies, 2008). Cand1 and 
FBXW7-Skp1 were purified as described in (Pierce et al., 2013). CSN was purified as 
described in (Enchev et al., 2012). Ubiquitin was purchased from Boston Biochem. Protein 
purity was assessed by SDS-PAGE and coomassie staining (Figs. S3A; S5D–F).
Quantitative reverse transcription PCR—Quantitative PCR (qPCR) was performed 
using primers specific to FBXO6 and Beta Actin mRNA following methodology described 
previously (Radhakrishnan et al., 2014). Briefly, RNA was isolated from Wt 
HEK2933xFLAG-Cul1 using the RNAeasy kit. Superscript III first strand synthesis kit was 
used to prepare cDNA. qPCR was performed using LightCycler 480 SYBR Green I Master 
reagent on a LightCycler 480 qPCR instrument (Roche).
SRM assay development—Peptide selection, SRM assay generation, and method 
optimization were developed following established guidelines (Picotti and Aebersold, 2012; 
Picotti et al., 2010). At least two (and in most cases three) unique tryptic peptides per protein 
were selected and synthesized as isotopically heavy (13C615N2-lysine and 13C615N4-
arginine) standards (Table S1A). Peptides that have been observed in-house were given top 
priority in peptide selection, but for those that have not been observed, we used SRMAtlas 
(Kusebauch et al., 2016). Unpurified peptides were pooled together in a 50 pmol/peptide/µl 
stock. The synthetic peptide mix with added indexed Retention Time (iRT) peptide mix 
(Escher et al., 2012) were analyzed on a QTRAP 6500 mass spectrometer (AB Sciex) in 
SRM-triggered MS2 mode to extract the most intense precursor ions, the 4 most SRM-
suitable transition ions, and the retention time for every peptide (Table S1A). The MS2 data 
were searched using Mascot. 0.75µg of peptide was injected into the instrument and was 
analyzed in SRM-scheduled mode. The data was analyzed using Skyline (MacLean et al., 
2010). Peptides that were undetectable and interfering product ions were manually removed. 
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Peptides were not considered for relative quantification if the most intense transition was 
less than 1,000 counts/second.
For the experiments in which we estimated the percent of all queried proteins bound to Cul1 
(Fig. 5; Fig. S4), lyophilized peptides from the FLAG immunoprecipitation and GST-
pulldown were resuspended in equal volumes of MS buffer (2% acetonitrile, 0.2% formic 
acid, 98% H2O), spiked with synthetic peptides standards, and 0.75µg was injected into the 
instrument. Data was normalized to injection volume.
Absolute quantification—To determine the cellular concentration of the invariant SCF 
subunits and regulatory proteins, HEK293 and 293T cells were grown for 12-cell doublings 
in isotopically heavy SILAC medium. Cells were harvested from 10 cm dishes and counted 
using a CEDEX HiRES automated cell counter (Roche), which determines average cell 
number and cell diameter from 20-technical replicates. The concentration of purified 
proteins (Fig. S5D–F) was determined on a NanoDrop (ThermoFisher). Cells were lysed in 
500 µl of lysis buffer (8 M Urea, 40 mM Tris (pH 8.0), 0.1 M ammonium bicarbonate, 5 mM 
TCEP) that was spiked with purified protein in similar amounts as described in (Bennett et 
al., 2010). Lysate was sonicated 2x for 10-seconds (20% maximum efficiency) and then 
centrifuged for 15 min at 15,000 RPM at 4°C. No insoluble pellet was observed using these 
conditions. The samples were digested as described in (Lee et al., 2011). Peptides were 
desalted using HyperSep C18 Cartridges. Data were analyzed using Skyline (MacLean et al., 
2010).
In order to test the overall accuracy of the standard/endogenous protein ratios reported by 
our SRM absolute quantification method, we spiked heavy cell lysates from 293T cells with 
5 different concentrations (1.56, 6.25, 25, 100, 400 nM) of light recombinant proteins and 
analyzed the samples via SRM. The computed standard/endogenous protein ratios were 
accurate over a range of three orders of magnitude.
For determining the cellular concentrations of FBPs and Cand2, a surrogate peptide for each 
protein was selected from our established SRM assay based on its consistent MS 
detectability, signal intensity, and amino acid composition (Table S1A–B) (Picotti and 
Aebersold, 2012; Schubert et al., 2013). Each protein was quantified by SRM by spiking 
lysis buffer with absolute-quantified heavy-isotope labeled standard peptide in defined 
concentrations. These heavy peptides include a trypsin-cleavable tag so that peptide 
digestion efficiency is similar to endogenous. Samples were then prepped as described in the 
previous paragraph. The measured concentrations of Cand1 and Skp1 were very similar to 
that measured using purified protein (Fig. S5A–B), supporting the method of using peptide 
surrogates to measure protein concentration.
The cellular concentrations reported in (Bennett et al., 2010) are lower and have a smaller 
Cul1:Cand1:Skp1 ratio than what we observe. We suspect that the discrepancy exists due to 
differing methods of sample preparation. Bennett et al., 2010, spiked their samples with 
AQUA peptides immediately prior to MS injection. This approach fails to account for 
peptide loss inherent to sample preparation. To account for peptide loss, we added either 
purified protein or peptide directly to our lysis buffer (Gerber et al., 2003; Mani et al., 2012).
Reitsma et al. Page 14
Cell. Author manuscript; available in PMC 2018 November 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Quantification and Statistical Analysis—Statistical analysis of SRM data is listed in 
Table S2. p-values were computed using limma (Ritchie et al., 2015; Smyth, 2004) on the 
log2 transformed protein ratios. P-values were adjusted for multiple hypothesis testing using 
the Benjamini and Hochberg method (Benjamini and Hochberg, 1995). All non-Western blot 
figures were generated using GraphPad Prism software.
SRM acquisition—Analysis of the samples was performed on the ABSciex QTRAP 6500 
LC-MS/MS system, equipped with an Eksigent ekspert nanoLC 425 pump, ekspert 
nanoLC400 autosampler, ekspert cHiPLC, and Analyst software. Samples were desalted 
using an on-line CHiPLC Chrom XP C18-CL 3 µm, 120 Å trap column (200 µm × 0.5 mm) 
then directed onto an analytical CHiPLC Chrom XP C18-CL 3 µm column, 120 Å (75 µm × 
150 mm) at a column temperature of 45°C. Chromatogr aphic separation was achieved using 
a 300 nl/min flow rate and a linear gradient of 5 to 30 % B within 45 min; 30–90 % B in 2 
min, followed by 100 % B for 10 min, solvent A was 0.2 % formic acid and solvent B was 
98.8 % acetonitrile containing 0.2 % formic acid.
For all SRM experiments, 6500 QTRAP acquisition parameters were as follows: 2000–2200 
V nano-spray voltage, curtain gas setting of 30 psi and nebulizer gas setting of 10 psi, 
interface heater at 15°C, 2.5 × 10−5 torr base pressure, and Q1 and Q3 set to unit resolution 
(0.6–0.8 Da full width at peak half-height).
SRM acquisition methods were constructed in Skyline (MacLean et al., 2010) using a 
maximum of 1,300 SRM transitions per injection with peptide-specific tuned declustering 
potential (DP), collision energy (CE) voltages, and retention time constraints. A default 
collision cell exit potential of 15 V was used for all SRM transitions, and the scheduled 
SRM option was used for all data acquisition with a target cycle time of 2 s and a 4-min 
SRM detection window.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Cand1-driven equilibration of SCF enzymes in lysate is quelled by molecular 
sponge
• Assembly of F-box proteins into SCF complexes ranges from 0–70%; median 
of ~19%
• Cellular SCF repertoire is tightly regulated by Nedd8 and Cand1/2
• Cells preferentially accumulate a specific SCF ligase when its substrate is 
present
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Fig. 1. Post-cell lysis exchange of FBPs is rapid and modulated by neddylation
(A) SILAC-SRM method used to measure percent exchange of FBPs in cell lysate. Cells 
were lysed in the presence of oPT and MLN4924 to inhibit Nedd8 deconjugation and 
conjugation, respectively. Percent exchange was determined based on the ratio of heavy to 
light protein that co-precipitated with 3xFLAGCul1, whereby a ratio of 1 indicates 100% 
exchange. IP: immunoprecipitation. (B) Time-dependent exchange of FBPs in cell lysate. 
When present, MLN4924 was added 30 minutes prior to lysis and IP. The red line represents 
the median % exchange. Slow (FBXO11 and FBXO9) and fast (Skp2 and FBXO31) 
exchangers are colored. (C) Average post-cell lysis exchange of core SCF subunits and 
representative FBPs. Each measurement in (B) and (C) is the average of 4 biological 
replicates, with ± SEM shown in (C). Statistically significant changes are presented in Table 
S2A
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Fig. 2. Post-lysis exchange of FBPs is mediated by Cand1/2
(A) SILAC SRM protocol used to measure the effect of Cand1/2 knockout on exchange in 
cell lysate. In each experiment, cells were mixed 1:1 prior to cell lysis and IP. (B) Cand1/2 
mediates exchange in cell lysate. Cells of indicated genotype were processed as described in 
(A). FBXO5/EMI1 is highlighted by green dots. Red bars indicated the median exchange 
and differences were considered significant at p≤0.05 (*). (C) Average exchange of core 
SCF subunits and representative FBPs. Data in (B) and (C) represent the average of 3 
biological replicates (mean ± SEM; p≤0.05 (*)). Statistically significant changes are 
presented in Table S2B. (D) Spiking DKO cell lysate with increasing concentrations of 
rCand1 results in loss of Skp1 and FBP assembly with Cul1. DKO cells were lysed in the 
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presence of rCand1 at 1x or 2x endogenous levels followed by IP of 3xFLAGCul1 and 
Western blot analysis.
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Fig. 3. Post-lysis exchange of FBPs is suppressed by addition of excess rCul1•Rbx1
(A) Scheme used to limit FBP exchange in cell lysate. The excess Cul1•GSTRbx1 should 
titrate Cand1/2 and thereby suppress their exchange activity. (B) Addition of excess 
rCul1GSTRbx1 suppresses post-lysis FBP exchange. rCul1GSTRbx1 was added to IP lysis 
buffer at 100x endogenous Cul1 levels. Cells were processed according to Fig. 1A and IP 
was for 20’. FBXO5/EMI1 is highlighted by green dots. Red bars indicate median exchange 
and differences were considered significant at p≤0.05 (*). (C) rCul1GSTRbx1 suppresses 
post-lysis exchange of Cand1, Skp1, and representative FBPs, but not the CSN complex. 
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Data in (B) and (C) represent the average of 3 biological replicates (mean ± SEM; p≤0.05 
(*)). Statistically significant changes are presented in Table S2C.
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Fig. 4. Post-lysis FBP exchange and Cul1 overexpression obscure regulation of SCF assembly by 
Nedd8 conjugation
(A) The effect of MLN4924 is largely eliminated upon IP under standard conditions. 
HEK2933xFLAG-Cul1 cells were pretreated ± 1µM MLN4924. Cells were lysed in the 
presence or absence of rCul1GSTRbx1 and subjected to IP with anti-FLAG for 20’ or 180’, 
as indicated. Fast (Skp2) and slow (βTrCP2) exchanging FBPs (Fig. S2A–C) were 
monitored by Western blot of the IPs. S.E.: short exposure. (B) Overexpression (O.E.) of 
Cul1 abolishes the effect of MLN4924. HEK293 Flp-in 3xFLAG-Cul1 were pretreated with 
tetracycline to induce 3xFLAG-Cul1 expression. HEK2933xFLAG-Cul1 and HEK293 Flp-in 
3xFLAG-Cul1 were then pretreated with MLN4924 and processed as described above. L.E.: 
long exposure. Endo: endogenous.
Reitsma et al. Page 26
Cell. Author manuscript; available in PMC 2018 November 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 5. Nedd8 conjugation and Cand1/2-mediated exchange sustain a non-equilibrium population 
of SCF ubiquitin ligases
(A) Heat map showing the percent binding of each FBP to Cul1. Wt and DKO HEK293 
(3xFLAGCul1) cells were treated ± 1µM MLN4924 for 30’ prior to lysis in the presence of 
excess rCu1•GSTRbx1. FBPs bound to endogenous Cul1 and those captured by recovering 
rCul1GSTRbx1 were monitored by SRM. The heat map is sorted relative to Wt-untreated 
from 70 (red) to 0% bound (white). FBPs not detected (ND) in either sample are shaded 
grey. Data represents the average of 4 biological replicates. Statistically significant changes 
are presented in Table S2D. (B) Percent of Cul1 occupied by Skp1, Cand1, and Cand2. 
Cellular concentrations were determined by SRM (Fig. S5A–B) and percent of Cul1 was 
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then derived from the percent that each protein assembles with Cul1. Data represent the 
mean of 2 biological replicates. (C) Heat map showing the cellular levels of individual SCF 
ligases. FBP concentrations in Wt and DKO cell lysate were determined by SRM (Fig. S5B) 
and the percent of Cul1 bound to each was determined as described above. Percent of SCF 
ligases was determined by summing the percent of Cul1 bound by the FBPs, and then 
dividing by the percent of Cul1 that is assembled with Skp1 (Fig. 5B). Data represent the 
mean of 2 biological replicates.
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Fig. 6. Signaling events alter the cellular repertoire of SCF ligases
(A) EGF treatment alters the repertoire of SCF ligases. Serum-starved Wt 
HEK2933xFLAG-Cul1 cells were treated ± 50 ng/ml of EGF for 15’. An equal number of cells 
were lysed in the presence of excess rCul1GSTRbx1, subjected to anti-FLAG IP, spiked with 
heavy synthetic peptide, and analyzed by SRM. Samples were normalized to the H/L ratio of 
Cul1 and presented as the +EGF/Control protein ratio. (B) Relative differences in the 
SCFome at two cell cycle checkpoint arrests. Wt HEK2933xFLAG-Cul1 cells were treated 
with either 100 ng/ml of nocodazole or 5 mM hydroxyurea for 16 hrs. Cells were lysed and 
prepared for SRM analysis as described above. NOC only: assembly of SCFcycF and 
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SCFFBXO8 was detected only in nocodazole-treated cells. Data from (A) and (B) represent 2 
biological replicates. Statistically significant changes from (A–B) are presented in Table 
S2E–F. (C) Heat map showing % binding of each FBP to Cul1 after DNA damage. Wt 
HEK2933xFLAG-Cul1 cells were treated with either DMSO or 50 µM of etoposide for 16 hrs. 
Cells were lysed in the presence of rCul1GSTRbx1. FBPs bound to endogenous Cul1 and 
those captured by recovering Cul1•GSTRbx1 were quantified by SRM. The heat map is 
sorted relative to Wt-untreated from 80 (red) to 0% bound (white). FBPs not detected (ND) 
in either sample are shaded grey. Data represents the average of 2 biological replicates. 
Changes were considered significant at p≤0.05 (*) (Table S2G). (D) Time-dependent 
accumulation of SCFFBXO6 after DNA damage. Wt HEK2933xFLAG-Cul1 cells were treated 
with either DMSO or 50 µM of etoposide or cisplatin (CPT) for the indicated time (CPT for 
16 hrs). Cells were lysed in the presence of excess rCul1GSTRbx1, subjected to anti-FLAG 
IP, and analyzed by Western blot.
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Fig. 7. Substrate drives SCF complex assembly in a Cand1/2- and neddylation-dependent 
manner
(A) Steady state assembly of osTir19xMyc with 3xFLAGCul1 in Wt and DKO cells in the 
absence of auxin. Wt and DKO HEK2933xFLAG-Cul1 cells stably expressing osTir19xMyc and 
Tet-inducible H2BAID-YFP were lysed in the presence of rCul1GSTRbx1 and subjected to IP 
with anti-Myc. The bound (IP) and unbound (FT) fractions were Western blotted with the 
indicated antibodies. (B) Degradation of H2B AID-YFP substrate is hindered in the absence of 
Cand1/2. The cell lines from (A) were treated with tetracycline for 24 hrs to activate 
H2BAID-YFP expression, treated with 500 µM auxin, and at the indicated time points after 
auxin addition samples were lysed and analyzed by Western blot. The half-life of 
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H2BAID-YFP was calculated from 2 biological replicates. (C) Auxin-induced osTir1 AID-YFP 
assembly with Cul1 is rapid. Wt cells from (A) were treated with 500 µM auxin for the 
indicated time, lysed in the presence of rCul1GSTRbx1, and subjected to IP followed by 
Western blot. (D) Auxin-driven SCFTir1 assembly peaks in 30’ and depends on Cand1/2. 
Cells from (A) were treated as described in (C) for the indicated amount of time. Fold 
change in osTir19xMyc association with 3xFLAGCul1 is displayed below. (E) Inhibition of 
neddylation blocks substrate driven SCF complex assembly. Same as (D) except cells were 
treated ± MLN4924 and auxin, as indicated, for 30’ prior to cell lysis. (F) Substrate 
increases the association of neddylated Cul1 interacting with osTir19xMyc. Cells were treated 
and processed as described above except that auxin treatment was for 30’ or 60’ and IP was 
for osTir19xMyc. Percent neddylated Cul1 (N8-Cul1) is indicated. S.E., L.E.: short and long 
exposures.
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